Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-09-28, Stock:LLY, The news for the past five days is as follows:
2018-09-21: NEWS1: Health Care Sector Update for 09/21/2018: CRSP,BGNE,XOMA,LLY,AGEN,INCY,MRK.NEWS2: Health Care Sector Update for 09/21/2018: CRSP,BGNE,XOMA,LLY,AGEN,INCY,MRK.NEWS3: [$$] Lilly Approval to Spur Migraine-Prevention Market in Europe.NEWS4: Market Rallies Despite Trade Worries: 5 Blue-Chip Picks.NEWS5: Market Rallies Despite Trade Worries: 5 Blue-Chip Picks.NEWS6: Market Rallies Despite Trade Worries: 5 Blue-Chip Picks.NEWS7: Health Care Sector Update for 09/21/2018: AGEN, XOMA, LLY, BGNE.NEWS8: Health Care Sector Update for 09/21/2018: AGEN, XOMA, LLY, BGNE.NEWS9: See what the IHS Markit Score report has to say about Eli Lilly And Co..NEWS10: Lilly Receives Positive CHMP Opinion for Emgality™ (galcanezumab) for the Prophylaxis of Migraine in Adults.NEWS11: Lilly migraine drug wins European panel thumbs-up.NEWS12: Lilly' Emgality Gets Positive CHMP Opinion For Prophylaxis Of Migraine In Adults.NEWS13: Lilly' Emgality Gets Positive CHMP Opinion For Prophylaxis Of Migraine In Adults.
2018-09-24: NEWS1: Cramer advises staying away from animal health play Elanc....NEWS2: Stay away from animal health play Elanco at these levels.NEWS3: Cramer advises staying away from animal health play Elanco at these levels.NEWS4: J&J&apos;s Esketamine Fails to Meet Endpoint in Phase III Study.NEWS5: Newly Public Elanco Seeks to Innovate With Offering Proceeds.NEWS6: Elanco Animal Health Incorporated Announces IPO Closing.NEWS7: Eli Lilly spin-off Elanco creating ‘disruptive’ opportunity in animal health: CEO.NEWS8: Lilly's Migraine Drug Emgality Wins Positive CHMP Opinion.NEWS9: Lilly's Migraine Drug Emgality Wins Positive CHMP Opinion.NEWS10: AstraZeneca's Diabetes Treatment Reduces Cardiovascular Risk.NEWS11: AstraZeneca's Diabetes Treatment Reduces Cardiovascular Risk.NEWS12: Elanco shares rally after successful IPO.NEWS13: Lilly&apos;s Migraine Drug Emgality Wins Positive CHMP Opinion.NEWS14: Elanco Announces Full Exercise of Additional Stock, Sets Date for Q3 Earnings.
2018-09-25: NEWS1: Elanco Animal Health IPO.NEWS2: Elanco Animal Health IPO.NEWS3: Elanco Animal Health IPO.NEWS4: A Brief Bird's Eye View of Fresh IPO Elanco Animal Health.NEWS5: Allergan’s Stock Price Performance in September.NEWS6: J&J's Esketamine Fails to Meet Endpoint in Phase III Study.NEWS7: J&J's Esketamine Fails to Meet Endpoint in Phase III Study.
2018-09-26: NEWS1: Chugai and Lilly Enter into a License Agreement for Oral GLP-1 Agonist, OWL833.NEWS2: Novartis to Cut Over 2000 Jobs, Focus on Higher Value Drugs.NEWS3: Novartis to Cut Over 2000 Jobs, Focus on Higher Value Drugs.NEWS4: Novartis to Cut Over 2000 Jobs, Focus on Higher Value Drugs.NEWS5: Pfizer’s Revenue and EPS Growth Rate.NEWS6: Glaxo's Tuberculosis Vaccine Positive in Mid-Stage Study.NEWS7: Glaxo's Tuberculosis Vaccine Positive in Mid-Stage Study.NEWS8: JPMorgan Resumes Coverage Of Eli Lilly: 'One Of The Best-Positioned Names In Our Group'.NEWS9: JP Morgan says buy Eli Lilly shares on its pipeline, predicts soaring profitability for drug maker.NEWS10: JP Morgan says buy Eli Lilly shares on its pipeline, predicts soaring profitability for drug maker.NEWS11: Is Eli Lilly and (LLY) Outperforming Other Medical Stocks This Year?.NEWS12: Is Eli Lilly and (LLY) Outperforming Other Medical Stocks This Year?.NEWS13: Glaxo&apos;s Tuberculosis Vaccine Positive in Mid-Stage Study.NEWS14: Analyzing Eli Lilly’s Valuation Trends.NEWS15: Is Eli Lilly and (LLY) Outperforming Other Medical Stocks This Year?.NEWS16: A Look at Eli Lilly’s Elanco Spin-Off.NEWS17: Allergan’s SpotLyte and Lumivive System.NEWS18: See what the IHS Markit Score report has to say about Eli Lilly And Co..NEWS19: Analyzing Perrigo’s Spin-Off of Its Rx Business.NEWS20: A Closer Look at the Allergan–Bonti Deal.
2018-09-27: NEWS1: Lilly's Emgality™ (galcanezumab-gnlm) Receives U.S. FDA Approval for the Preventive Treatment of Migraine in Adults.NEWS2: FDA Approves Lilly's Emgality For Preventive Treatment Of Migraine In Adults.NEWS3: FDA Approves Lilly's Emgality For Preventive Treatment Of Migraine In Adults.NEWS4: MannKind Stock History.NEWS5: MannKind Stock History.NEWS6: U.S. judge dismisses Teva lawsuits against Lilly on migraine drug.NEWS7: Trade of the Day: Eli Lilly (LLY).NEWS8: Trade of the Day: Eli Lilly (LLY).NEWS9: Here's Why Eli Lilly (LLY) is a Great Momentum Stock to Buy.NEWS10: Here's Why Eli Lilly (LLY) is a Great Momentum Stock to Buy.NEWS11: Big Pharma Players on Strong Footing Ahead of Q4: 4 Picks.NEWS12: Big Pharma Players on Strong Footing Ahead of Q4: 4 Picks.NEWS13: Here&apos;s Why Eli Lilly (LLY) is a Great Momentum Stock to Buy.NEWS14: Big Pharma Players on Strong Footing Ahead of Q4: 4 Picks.NEWS15: A Look at Pfizer’s Market Cap and Shareholding Pattern.NEWS16: Trade of the Day: Eli Lilly (LLY).NEWS17: The Daily Biotech Pulse: Hologic Goes Shopping, Johnson & Johnson Snaps Ties With Geron.NEWS18: Assessing Pfizer’s Global Performance.

Answer: Rise